会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 47. 发明专利
    • PM21 PARTICLES TO IMPROVE BONE MARROW HOMING OF NK CELLS
    • SG11201907917XA
    • 2019-09-27
    • SG11201907917X
    • 2018-02-28
    • UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION INCRES INST NATIONWIDE CHILDRENS HOSPITAL
    • COPIK ALICJAOYER JEREMIAHCHAKRAVARTI NITINLEE DEAN ANTHONY
    • A61K35/17A61K38/20C12N5/00
    • PMg/injection) PM21 (14/injection) .2 , 0,000 .50,000 Lung r, 60,000 .E 40,000 S 20 , 000 Liver o P=0.0003 o 0 0 o o 0 o° = —41 - o 0 0 o 0 800 0 800 PM21 (µg/injection) PM21 (µg/injection) 4;120% - P=0.012 ••\"100% +- 100% 80%-e 80% 60% _O R s . E 60% s ÷: 40%-o - o ( !1, 161 ig 40% 20 0% -1 30 % o 4tiSt 421t, 20%-g 0%- azt, sca, O 800 0 800 0 o ° o 0 P=0.035 00 1 -o P=0.015 0 120%- P=0.018 1 + -1oo: : '4 1 80% - LI g 40%- oo h o o c, 20% Eb?, 0% - e lm imok 0 800 PM21 (µg/injection) PM21 (vg/injection) PM21 (µg/injection) FIG. 5 - 100% 80% ' 4 ,2 - 60% '4, 40% • 20% 0% 0 0 otio PM21 (µg/injection) 80,000 460,000 .E 40,000 20,000 o Spleen Brain 0 0 800 PM21 (µg/injection) 0 800 PM21 (11g/injection) 120%- + 100% 80% a 60% • 40% c, 20% 0% D iz.xc 800 - 0 4E4 800 la 10,000 1 5,000 4 ' 000 f 2 •, 2,000 Bone marrow P=0.044 00 (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 07 September 2018 (07.09.2018) WIP0 I PCT 011101010 0111 °nolo omiooliolioomll ono voimIE (10) International Publication Number WO 2018/160673 Al (51) International Patent Classification: A61K 35/17 (2015.01) Cl 2N 5/00 (2006.01) A61K 38/20 (2006.01) (21) International Application Number: PCT/US2018/020187 (22) International Filing Date: 28 February 2018 (28.02.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/464,747 28 February 2017 (28.02.2017) US (71) Applicants: UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. [US/US]; 12201 Research Parkway, Ste 501, Orlando, Florida 32826 (US). RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL [US/US]; 700 Children's Dri- ve, Columbus, Ohio 43205 (US). (72) Inventors: COPIK, Alicia; 196 Paul McClure Ct., Cassel- berry, Florida 23707 (US). OYER, Jeremiah; 609 Albany Ct., Longwood, Florida 32779 (US). CHAKRAVARTI, Nitin; 2801 River Park Drive, Columbus, Ohio 43220 (US). LEE, Dean Anthony; 2561 Sitterly Road, Canal Winches- ter, Ohio 43110 (US). (74) Agent: LANIER, Gibson, J. et al.; Meunier Carlin & Curf- man LLC, 999 Peachtree Street, NE, Suite 1300, Atlanta, Georgia 30309 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, (54) Title: PM21 PARTICLES TO IMPROVE BONE MARROW HOMING OF NK CELLS © (57) : Disclosed are compositions and methods for directing NK cells to the bone marrow through the use of PM21 particles. C [Continued on next page] WO 2018/160673 Al MIDEDIMOMMIDIRE1013 0111 VIII 1101 INEHOMOVOIS TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3))
    • 48. 发明专利
    • METHODS AND COMPOSITIONS RELATED TO NK CELL AND ANTI-PDL1 CANCER THERAPIES
    • SG11201903032SA
    • 2019-05-30
    • SG11201903032S
    • 2017-10-05
    • UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION INC
    • COPIK ALICJA JIGARASHI ROBERT YOYER JEREMIAH JALTOMARE DEBORAH A
    • C12N1/15C12N1/19C12N1/21C12N5/078C12N5/10C12N15/09
    • 100% CD 121 80% 71 3 60% 0 40% >, 20% U- 0% FIG. 1 (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 12 April 2018 (12.04.2018) iiiionomoloionlio1 001110110011101110MOVON (10) International Publication Number WO 2018/067825 Al WIPO I PCT (51) International Patent Classification: C12N 1/15 (2006.01) C12N 5/078 (2010.01) C12N 1/19 (2006.01) C12N 5/10 (2006.01) C12N 1/21 (2006.01) C12N 15/09 (2006.01) (21) International Application Number: PCT/US2017/055352 (22) International Filing Date: 05 October 2017 (05.10.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/404,520 05 October 2016 (05.10.2016) US (71) Applicant: UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. [US/US]; 12201 Re- search Parkway, Suite 501, Orlando, Florida 32826 (US). (72) Inventors: COPIK, Alicia J.; 12201 Research Parkway, Suite 501, Orlando, Florida 32826 (US). IGARASHI, Robert Y.; 12201 Research Parkway, Suite 501, Orlando, Florida 32826 (US). OYER, Jeremiah J.; 12201 Research Parkway, Suite 501, Orlando, Florida 32826 (US). AL- TOMARE, Deborah A.; 12201 Research Parkway, Suite 501, Orlando, Florida 32826 (US). (74) Agent: LANIER, J. Gibson et al.; Meunier Carlin & Curf- man LLC, 999 Peachtree Street, NE, Suite 1300, Atlanta, Georgia 30309 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, (54) Title: METHODS AND COMPOSITIONS RELATED TO NK CELL AND ANTI-PDL1 CANCER THERAPIES IFNI production upon tumor or cytokine stimulation is highly enhanced for PM21 expanded NK cells 1-1 (57) : Disclosed are compositions and methods relating to the treatment of a cancer via the induction of PDL1 and use of ei anti-PDL1 antibodies. o [Continued on next page] cc O WO 2018/067825 Al MIDEDIMOMOIDEIRMOIMEHERIOMMWS TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: — of inventorship (Rule 4.17(iv)) Published: — with international search report (Art. 21(3))